Jennifer Gunter
Obstetrician-gynecologist and author of The Vagina Bible and The Menopause Manifesto. Writes The Vajenda newsletter on women's health, menopause, hormone therapy and health misinformation.
Jennifer Gunter did not write this page.
We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.
Filter All topics · Newest first
-
Their wordsStudies using the TriNexT database have too many issues to be highly reliable regarding causal effects of testosterone.
↗Testosterone and Heart Diseasevajenda.substack.com 1st of 2 in this piece
-
Their wordsThis latest testosterone abstract does not prove that testosterone causes heart disease in postmenopausal women, just as last year's estrogen abstract did not prove that hormone therapy prevents disease in perimenopause.
↗Testosterone and Heart Diseasevajenda.substack.com 2nd of 2 in this piece
- 5 days earlier
-
Their wordsWhile guidelines don't compel anyone, they can influence insurers, pharmacy benefit managers, or governments to cover therapies and may also affect the price.
↗The Price of a Hot Flashvajenda.substack.com 1st of 3 in this piece
-
Our reading
The ACP guideline's exclusion of tibolone lacks sufficient evidence to justify safety concerns.
Their wordsThe guideline excluded tibolone for what the authors write are "safety reasons," but they provide no analysis showing why its safety profile would preclude its use for hot flashes and night sweats.
↗The Price of a Hot Flashvajenda.substack.com 2nd of 3 in this piece
-
Their wordsDemoting a drug to a third tier based on cost becomes a self-fulfilling prophecy, as many insurers and pharmacy benefit managers look at these tiers to design coverage or as excuses to exclude the more expensive drugs.
↗The Price of a Hot Flashvajenda.substack.com 3rd of 3 in this piece
- 5 weeks earlier
-
Their wordsBone loss during perimenopause is likely a multi-hormone event.
↗Bone Health Without the Hypevajenda.substack.com 1st of 2 in this piece
-
Their wordsDenosumab is a fantastic antiresorptive medication, but people need to be on it continuously and cannot just stop it as rapid loss of bone in the 12 months after stopping can occur.
↗Bone Health Without the Hypevajenda.substack.com 2nd of 2 in this piece
- 9 days earlier
-
Their wordsWomen who are using compounded testosterone have every reason to worry that their products may not be formulated consistently or match the labeling.
↗The Problem with Compounded Testosteronevajenda.substack.com 1st of 3 in this piece
-
Their wordsIn the United States and Canada, there are no regulations requiring compounders to prove that what they make contains what it claims or that it actually works.
↗The Problem with Compounded Testosteronevajenda.substack.com 2nd of 3 in this piece
-
Their wordsThe one study we have showed that the amount of testosterone in compounded gels and creams can vary substantially from the prescribed concentration, which is not unexpected.
↗The Problem with Compounded Testosteronevajenda.substack.com 3rd of 3 in this piece
- 7 days earlier
-
Their wordsThe results are precisely the pattern that argues AGAINST broad use of MHT to prevent dementia. The women who benefited the most had shorter reproductive years or surgical menopause, which, if the results of the study are true (and we can't know if they are as it is observational...and we will get into all the issues with the UK Biobank and MHT studies shortly), they support the conclusion that MHT is NOT broadly neuroprotective.
↗Before You Share That New "HRT Prevents Dementia" Study, Read the Fine Printvajenda.substack.com 1st of 3 in this piece
-
Their wordsOne big reason is that healthier, wealthier women tend to use MHT, which creates a meaningful difference between MHT users and non-users, so we must be careful when attributing any benefit to MHT rather than to the healthy-user effect.
↗Before You Share That New "HRT Prevents Dementia" Study, Read the Fine Printvajenda.substack.com 2nd of 3 in this piece
-
Their wordsPeople in the UK Biobank are overall healthier than the general U.K. population, so it is not a representative sample of people on or off MHT.
↗Before You Share That New "HRT Prevents Dementia" Study, Read the Fine Printvajenda.substack.com 3rd of 3 in this piece
- 4 weeks earlier
-
Their wordsTestosterone levels do not reliably distinguish women with symptoms from those without.
↗MIDI and the Making of Female Testosterone Deficiencyvajenda.substack.com 1st of 3 in this piece
-
Their wordsOutside of sexual desire disorders, studies have not demonstrated a meaningful benefit of using testosterone therapy.
↗MIDI and the Making of Female Testosterone Deficiencyvajenda.substack.com 2nd of 3 in this piece
-
Their wordsThe Endocrine Society (2014) and the Global Consensus Statement on Testosterone (2019) both concluded there is no established clinical syndrome or testosterone level that defines testosterone deficiency for women.
↗MIDI and the Making of Female Testosterone Deficiencyvajenda.substack.com 3rd of 3 in this piece